ArticleGastro hep advances2025

All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors.

Samita Garg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.